NCT07231471 Platelet Rich Plasma for Musculoskeletal Conditions
| NCT ID | NCT07231471 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Utah |
| Condition | Osteoarthritis (OA) |
| Study Type | INTERVENTIONAL |
| Enrollment | 10,000 participants |
| Start Date | 2025-12-29 |
| Primary Completion | 2035-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 10,000 participants in total. It began in 2025-12-29 with a primary completion date of 2035-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The primary purpose of this study is to follow patients with various musculoskeletal (MSK) conditions over a one-year follow-up period after receiving a platelet rich plasma (PRP) injection, assessing changes in their pain levels, functional abilities, and overall patient satisfaction. This will develop a robust registry of patients treated with PRP for a range of MSK conditions. These conditions include, but are not limited to, osteoarthritis (OA) of the knee, hip, glenohumeral joint, elbow, ankle, and sacroiliac joint, as well as rotator cuff tendinopathy, lateral and medial epicondylitis, plantar fasciitis, patellar tendinopathy, Achilles tendinopathy, and proximal hamstring tendinopathy.
Eligibility Criteria
Inclusion Criteria: * 18+ years old * Musculoskeletal pathology that may benefit from a PRP injection * Failed other conservative treatments Exclusion Criteria: * No active malignancy * No active infection in the area of injection * No platelet disorder * No active systemic infections * No patients currently undergoing dialysis
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07231471 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Osteoarthritis (OA). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07231471 currently recruiting?
Yes, NCT07231471 is actively recruiting participants. Contact the research team at christina.geisler@utah.edu for enrollment information.
Where is the NCT07231471 trial being conducted?
This trial is being conducted at Salt Lake City, United States.
Who is sponsoring the NCT07231471 clinical trial?
NCT07231471 is sponsored by University of Utah. The trial plans to enroll 10,000 participants.